| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 74.896 | 113.495 | 82.018 | 119.636 | 189.773 | 373.442 |
| Total Income - EUR | - | - | - | 0 | 74.903 | 113.529 | 82.052 | 120.478 | 191.098 | 376.770 |
| Total Expenses - EUR | - | - | - | 3.731 | 47.573 | 78.871 | 81.222 | 104.568 | 149.357 | 242.276 |
| Gross Profit/Loss - EUR | - | - | - | -3.731 | 27.330 | 34.659 | 830 | 15.910 | 41.741 | 134.495 |
| Net Profit/Loss - EUR | - | - | - | -3.731 | 25.083 | 33.253 | 10 | 14.705 | 39.830 | 123.192 |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Transfer Pharma Solutions S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 24 | 26.778 | 21.455 | 42.507 | 31.754 | 23.511 |
| Current Assets | - | - | - | 389 | 32.533 | 60.747 | 24.631 | 49.929 | 176.238 | 207.496 |
| Inventories | - | - | - | 0 | 10.430 | 2.770 | 394 | 7.113 | 12.286 | 63.493 |
| Receivables | - | - | - | 381 | 13.377 | 18.242 | 14.965 | 47.373 | 140.195 | 126.838 |
| Cash | - | - | - | 8 | 8.725 | 39.735 | 9.272 | -4.557 | 23.757 | 17.165 |
| Shareholders Funds | - | - | - | -3.688 | 21.466 | 33.302 | 58 | 14.764 | 39.888 | 123.250 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 4.077 | 11.096 | 54.989 | 47.801 | 78.321 | 170.666 | 108.434 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Transfer Pharma Solutions S.r.l.